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Oral bacteria live in symbiosis with the host. Therefore, when mouthwashes are indicated,
selective inhibition of taxa contributing to disease is preferred instead of broad-spectrum
antimicrobials. The potential selectivity of an oxygenating mouthwash, Ardox-X® (AX), has
not been assessed. The aim of this study was to determine the antimicrobial potential of
AX and the effects of a twice-daily oral rinse on dental plaque composition.
Material and methods: In vitro, 16 oral bacterial strains were tested using agar diffusion
susceptibility, minimum inhibitory and minimum bactericidal concentration tests. A pilot
clinical study was performed with 25 healthy volunteers. Clinical assessments and
microbiological sampling of supragingival plaque were performed at 1 month before the
experiment (Pre-exp), at the start of the experiment (Baseline) and after the one-week
experimental period (Post-exp). During the experiment individuals used AX mouthwash
twice daily in absence of other oral hygiene measures. The microbiological composition of
plaque was assessed by 16S rRNA gene amplicon sequencing.
Results: AX showed high inter-species variation in microbial growth inhibition. The
tested Prevotella strains and Fusobacterium nucleatum showed the highest sensitivity,
while streptococci and Lactobacillus acidophilus were most resistant to AX. Plaque
scores at Pre-exp and Baseline visits did not differ significantly (p = 0.193), nor did the
microbial composition of plaque. During a period of 7-days non-brushing but twice daily
rinsing plaque scores increased from 2.21 (0.31) at Baseline to 2.43 (0.39) Post-exp.
A significant microbial shift in composition was observed: genus Streptococcus and
Veillonella increased while Corynebacterium, Haemophilus, Leptotrichia, Cardiobacterium
and Capnocytophaga decreased (p ≤ 0.001).
Conclusion: AX has the potential for selective inhibition of oral bacteria. The shift in oral
microbiome after 1 week of rinsing deserves further research.
Keywords: microbiome, selective inhibition, oxygenating agents, antimicrobials, Ardox-X®-technology
INTRODUCTION
Dental plaque biofilm is part of the oral microbiome that co-
evolves in symbiosis with the human host (Marsh, 2012). Recently
the importance and beneficial role of the oral microbiome in
maintaining oral and general health has been brought forward
(Marsh, 2012; Hezel and Weitzberg, 2013). On the other hand,
undisturbed dental plaque accumulation is associated with an
enhanced host inflammatory response and gingival inflammation
(gingivitis) (Lee et al., 2012). Gingivitis is known to be associated
with the onset of periodontitis (Schatzle et al., 2003), therefore
the importance of maintaining gingival health is well understood.
Although regular mechanical plaque removal is recommended
for prevention of periodontal diseases, the quality of self-
performed mechanical plaque removal may not always be suf-
ficient (Hioe and van der Weijden, 2005). When this fails or
cannot be optimally maintained, for instance in physically or
mentally disabled populations, a chemical approach, such as the
use of an antimicrobial mouthwash, can be an alternative or an
adjunct.
Anti-plaque agents should not eradicate the oral microbiota.
Instead, they should maintain the microbiota of the mouth at the
level and composition that is compatible with oral health, this way
preserving the beneficial functions of resident microbes (Marsh,
2012; ten Cate and Zaura, 2012). This requirement is not met by
so-called broad spectrum antimicrobial agents such as chlorhex-
idine (CHX). Interestingly, oxygenating mouthwashes containing
peroxoborate are able to reduce the dental plaque amount and
retard the colonization and growth of anaerobes (Wennstrom
and Lindhe, 1979; Binney et al., 1992; Moran et al., 1995) and
Gram-negative bacteria (Hernandez et al., 2013). Gram-negative
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anaerobes are generally associated with oral infections (e.g., peri-
odontitis, peri-implantitis, endodontic infections).
Among oxygenating agents, boron-derived compounds such
as sodium perborate (peroxoborate) generate active oxygen in
aqueous solutions. This characteristic is the basis for their use
as bleaching agents in detergents, cleaning products and cos-
metic preparations, as well as a preservative in eye drops (Safety,
2010). In clinical dentistry, boron-derived compounds are used
as a bleaching agent for teeth and as an adjunct to CHX to coun-
teract extrinsic staining of the tongue and tooth surfaces (Dona
et al., 1998; Grundemann et al., 2000; van Maanen-Schakel et al.,
2012; Feiz et al., 2014).
Ardox-X® technology (AX) was introduced to the market
and promoted as a teeth whitening, anti-microbial, anti-fungal
and anti-inflammatory compound (NGen Oral Pharma, www.
ngenpharma.com)1. According to the manufacturer, the AX com-
pound is formed by chemical complexation of peroxoborate
with specific carriers such as glycerol and cellulose. This pro-
duces sodiumperborate-1,2-diol-glycerol/cellulose-ester adducts,
i.e., single-reaction products containing all the atoms of all
components. The manufacturer considers this to be a dis-
tinct molecular compound that provides controlled release of
active oxygen without generating hydroxyl radicals. However, the
scientific evidence for the antimicrobial efficacy of this com-
pound is scarce. So far, only one in vitro study has been pub-
lished which showed that AX has an antimicrobial effect against
polymicrobial biofilm (microcosm) grown on titanium surfaces
(Ntrouka et al., 2011).
The aims of the current study were: first, to determine the
antimicrobial effect of AX against oral bacteria in vitro; second,
to evaluate in vivo the effect of AX containing mouthwash on the
composition of undisturbed plaque accumulation in a one-week
non-brushing model in healthy adults.
MATERIALS AND METHODS
IN VITRO STUDY
Bacterial strains (Table 1) were cultured on blood agar plates
(Oxoid no 2, Oxoid, Basingstoke, UK) supplemented with 5%
horse blood, 0.1% (w/v) haemin and 0.01% (w/v) menadione.
For Tannerella forsythia Trypticase Soy Agar (TSA) (BBL, Beckton
Dickson Microbiology Systems, Cockeyscille, MD) was used sup-
plemented with 5% horse blood, 0.1% (w/v) N-acetyl muraminic
acid (TSNAM plates), 0.05% (w/v) haemin, and 0.01% (w/v)
menadione (van der Reijden et al., 2006). All strains except
Staphylococcus aureus HG386 were grown in anaerobic atmo-
sphere containing 80% N2, 10% CO2, and 10% H2. S. aureus was
grown aerobically.
For this study, the manufacturer provided different concen-
trations of AX in standard equivalent units (SE) in a range 1–20
SE, where 1 SE contains 0.27% (w/v) of sodium perborate (SP),
as well as the AX blank (AX without sodium perborate; NGen
Oral Pharma1; Curacao; van den Bosch, 2000, US patent number
6.017.515) that was used as negative control. As positive controls,
two different concentrations of over-the-counter chlorhexidine
(CHX) products were used: Perio Aid (0.12% CHX) (Dentaid,
1http://www.ngenpharma.com (Accessed 08 April, 2014).
Table 1 | Bacterial strains and their abbreviations used in the text.
Strain Abbreviation
Actinomyces naeslundii ATCC 12104 An
Aggregatibacter actinomycetemcomitans HG 683* Aa
Campylobacter rectus HG 963* Cr
Fusobacterium nucleatum ATCC 25586 Fn
Lactobacillus acidophilus ATCC 4356 La
Parvimonas micra HG 1179* Pm
Porphyromonas gingivalis K- HG 91* Pg K-
Porphyromonas gingivalis K1 HG 66/W83* Pg K1
Porphyromonas gingivalis K6 HG 1691* Pg K6
Prevotella intermedia HG 110* Pi
Prevotella nigrescens HG 70* Pn
Staphylococcus aureus ATCC 2592 Sa
Streptococcus mutans HG 708* Sm
Streptococcus sanguinis HG 1471* Ss
Tannerella forsythia ATCC 43037 Tf
Veillonella parvula HG 318* Vp
*Clinical isolates.
Barcelona, Spain) and Corsodyl (0.2% CHX) (GlaxoSmithKline,
Zeist, the Netherlands).
Agar diffusion tests were performed as described before
(Clinical and Laboratory Standards Institute, 2009). For each
strain, two blood agar plates were inoculated with 100µl sus-
pension of a single colony suspended in 5ml phosphate buffered
saline (PBS). The compounds were added in 5mm holes punched
in the agar. Five concentrations of AX (1.36; 1.9; 2.72; 4.08;
5.44%) together with a blank and two CHX concentrations were
used. The blank and AX (2.72%) were included in each agar plate
(twice per strain). Agar plates were incubated for 7 days at 37◦C
under anaerobic conditions (10% CO2, 10% H2, and 80% N2).
After incubation, plates were examined for growth inhibition. The
inhibition zone around the holes was measured and expressed in
mm from the edge to the nearest CFU.
Serial dilutions were used to determine the minimum
inhibitory concentration (MIC) (Hecht, 2007) and the minimum
bactericidal concentration (MBC) of AX. Two 24-wells plates
were used per dilution set of 4 strains. The medium consisted
of Brain Heart Infusion (BHI) broth (Oxoid, Basingstoke, UK)
supplemented with 0.1% haemin and 0.01% menadione (h/m).
For Tannerella forsythia filter-sterilized N-acetyl-muraminic acid
(NAM) to a final concentration of 0.1% (w/v) was added. The
compound was filter-sterilized (0.2µm pore size; 7 bar max
Whatman, Germany). The initial dilution for the MIC was pre-
pared using 0.5ml AX at the highest concentration (54.4 g/l) in
two-fold serial dilution series (range 40–40, 800mg/l)
Inocula were prepared from a pure culture of each strain. A
single colony was taken using a sterile cotton pick and suspended
in 5ml of PBS. Then 50µl of suspension were dispensed into each
labeled well. Plates were incubated for 7 days at 37◦C under anaer-
obic conditions (10% CO2, 10% H2, and 80% N2). After 1 week
the MICs were determined by visual means. The procedure was
performed in triplicate at different time points.
After MIC determination, 100-µl samples from the vari-
ous dilutions were inoculated onto appropriate agar plates and
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incubated for 7 days at 37◦C under anaerobic conditions (10%
CO2, 10% H2, and 80% N2). The concentration at which growth
was visibly inhibited was defined as the MBC.
PILOT CLINICAL STUDY
The study protocol was approved by the Medical Ethics
Committee of the Academic Medical Center (AMC) of
Amsterdam (NL37567.018.11) and registered at the Dutch trial
register under the number NTR3145. The study followed the
instructions based on the declaration of Helsinki. That statement
acts as a starting point in subject recruitment.
Study population
Participation in this study was voluntary. Before enrollment all
participants were given oral and written information about the
products and the reason, aim, duration, demands of benefits and
possible harm. After signing a declaration of informed consent,
26 systemically healthy participants meeting the inclusion criteria
agreed to participate in the study.
All participants (non-dental students, ≥18 years) had to be
dentate with at least 5 evaluable teeth per quadrant excluding
prosthetic crowns. To include a population with high plaque
scores at the start of the experimental period, participants were
selected that had an overnight plaque score of 2 or higher
as assessed according to Modified Quigley & Hein Plaque
index (Paraskevas et al., 2007). Exclusion criteria were: oral
mucosal lesions, orthodontic appliances, removable (partial) den-
tures, and overhanging margins of dental restorations (clinically
assessed with a periodontal probe), the use of antibiotics during
the last 6 months, Dutch Periodontal Screening Index (Mantilla
Gomez et al., 2001) (DPSI) ≥3+ (periodontal pockets >5mm
with bleeding on probing and gingival recession), the use of med-
ication possibly influencing normal gingival health, pregnancy
and smoking.
Test compound
According to the manufacturer, the hydro-carbon-oxo-borate
compound AX had the following ingredients: aqua, sodium lauryl
sulfate, PEG-40 hydrogenated castor oil, sodium gluconate, cel-
lulose gum, aroma, sodium citrate, magnesium sulfate, sodium
perborate, sodium methylparaben, citric acid, sodium chlo-
ride, sodium fluoride, sodium saccharin NGen Oral Pharma,
www.ngenpharma.com1; van den Bosch, 2000, US patent number
6.017.515 .
Study design
The study started with a pre-experimental appointment (1 month
prior to baseline) during which dental plaque was scored and
sampled with the intention to assess the consistency of collected
plaque scores and microbiological data relative to the baseline. At
baseline, dental plaque was again scored and sampled. In addi-
tion, the level of bleeding on marginal probing was assessed as a
descriptive of the oral health status of the included subjects. After
the baseline measurements, a professional prophylaxis was per-
formed by a dental hygienist as described in detail by Slot et al.
(2010) in order to start the experiment with equally clean teeth.
Following the prophylaxis, a one-week non-brushing experimen-
tal period of undisturbed plaque accumulation was started. With
respect to oral hygiene the participants were only allowed rins-
ing with the distributed mouthwash (AX). Each subject received
an instruction form on how to use the intervention product
and the first rinse was performed under supervision. Participants
were instructed to rinse twice daily (morning and evening) for
1min and not to rinse, drink or eat for at least 30min thereafter.
No other form of oral hygiene during the subsequent week was
allowed, including chewing gum (Keukenmeester et al., 2014) or
any xylitol containing sweets or gum (Soderling, 2009).
Clinical assessments
In the study a partial-mouth model (Bentley and Disney, 1995)
was used. Two contra-lateral randomly chosen quadrants (www.
random.org) served for the collection of dental plaque biofilm
that was not disturbed by scoring or the disclosing solution (one
in the upper and one in the lower jaw; Heijnsbroek et al., 2006;
Van Leeuwen et al., in press).
The two opposing contra-lateral quadrants were used for the
clinical plaque assessments. All teeth in each of the two quadrants
were examined except third molars. Scoring was performed by
two experienced examiners each responsible for scoring one clin-
ical parameter (plaque or bleeding) separately. For plaque scores
teeth were disclosed with a 1% erythrosine solution. Plaque was
assessed at six sites per tooth on a six-point scale using the Quigley
& Hein’s plaque index (Quigley and Hein, 1962) as modified by
Turesky et al. (1970) and further modified by Lobene et al. (1982),
in which the absence or presence of plaque was recorded on a 0–5
scale (0 = no plaque, 5 = plaque covering more than two-thirds
of the tooth surface) and described in detail by Paraskevas et al.
(2007). At the baseline appointment the level of oral health was
assessed in the two contra-lateral quadrants that had previously
been sampled for supragingival plaque using the Bleeding on
Marginal Probing (BOMP) score (van der Weijden et al., 1994a,b;
Lie et al., 1998). Bleeding was elicited with aWHO-approved ball-
ended probe (Ash Probe EN15, Dentsply International, York, PA,
USA). The absence or presence of bleeding was scored within 30 s
of probing on a scale of 0–2 (0 = non-bleeding, 1 = pinprick
bleeding, 2 = excess bleeding).
Sampling procedure
Since it is imperative to characterize differences in microbial
composition among specific oral locations, supragingival dental
plaque was collected from the buccal sites of four pre-selected
teeth being the same at all three assessments (first molar and
canine, upper and lower jaw). Dental plaque was carefully col-
lected by an experienced examiner with a sterile microbrush
(Microbrush International, Grafton, USA) per tooth moving over
the enamel surface from themesial to distal curvature of the tooth
crown along the gingival margin and tooth-surface border. The
tip of each of the four microbrushes was clipped off and placed
in a single vial containing RNAProtect Bacteria reagent (Qiagen,
Hilden, Germany). Samples were coded, kept on ice until transfer
within 2 h to the laboratory.
DNA extraction, amplicon preparation, and pyrosequencing
Of the 72 clinical samples belonging to 25 subjects, 6 sam-
ples were lost due to technical reasons. DNA was extracted
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with the AGOWA mag Mini DNA Isolation Kit (AGOWA,
Berlin, Germany) as described previously (Crielaard et al., 2011).
Barcoded amplicon libraries of the small subunit ribosomal RNA
gene hypervariable region V5–V7 were generated for each of the
individual sample as described previously (Kraneveld et al., 2012),
pooled and sequenced by means of the Genome Sequencer FLX
Titanium system (Roche Molecular Diagnostics). The sequenc-
ing data was processed using Quantitative Insights Into Microbial
Ecology (QIIME) (Caporaso et al., 2010) version 1.5.0. The reads
were denoized using Denoiser version 1.3.0 (Reeder and Knight,
2010) and checked for chimeric sequences using UCHIME ver-
sion 4.2.40 (Edgar et al., 2011). The results of the de novo and the
reference-based approach were combined and reads marked as
chimeric were removed. Sequences were clustered in operational
taxonomic units (OTUs) at 97% similarity.
Statistical analyses
The statistical package SPSS software version 19.0 was used to per-
form statistical analyses. The effect of AX on bacterial strains in
the agar diffusion assay was analyzed for each AX concentration
relative to the effect of 0.2%CHX for each bacterial strain (Mann–
Whitney test). Differences among strains per-compound were
calculated using One-Way ANOVA and Tukey B post-hoc test.
For the clinical study, the mean plaque score and gingival
bleeding score were calculated first per participant. Additionally
the mean bleeding score at baseline for the sampled teeth was
calculated. Plaque scores were tested for normality using the
Shapiro–Wilk test. Non-parametric Wilcoxon Signed Rank test
was performed to test for differences in plaque scores between the
three visits: pre-experimental, baseline and post-experimental.
To normalize the microbial data for comparisons among dif-
ferent samples and to avoid the effect of variable sample size on
the diversity analyses, a randomly subsampled data set of 850
reads per sample was created. This resulted in exclusion of addi-
tional five samples with less than 850 reads/sample. PAST software
(Hammer et al., 2001) was used to calculate Shannon diversity
index, which takes into account the abundance of each OTU, as
well as the number of OTUs. The normality of the diversity index
data was assessed using Shapiro–Wilk test. Paired samples T-test
was used to compare the diversity indices between the three time
points. OTU-significance paired samples T-test implemented in
QIIME 1.5.0 was used to compare the abundances of OTUs at
baseline and post-experimental samples. Only those OTUs that
were present in at least 10 samples were included in the analy-
ses, resulting in 75 comparisons. The p-values were corrected for
thesemultiple comparisons using Bonferroni correction. P-values
below 0.05 were considered statistically significant.
To visualize microbial profile data, principal component anal-
ysis (PCA) was used in PAST. The OTU abundances were log2
transformed to normalize the data distribution.
RESULTS
IN VITRO STUDY
Based on the size of the inhibition zone (mm), the efficacy of CHX
was greater than that of AX at all concentrations tested and for all
bacterial strains (p < 0.05). AX showed high variation in inhibi-
tion (Figure 1), which was statistically significant among various
strains (Table 2). Streptococcus mutans, Lactobacillus acidophilus
and Streptococcus sanguinis were the least affected (inhibition
zone 0–0.3mm), while Prevotella nigrescens (9mm) and Prevotella
intermedia (9mm)—the most p < 0.05 (Table 2).
All tested strains were inhibited by CHX and the differences in
inhibitory activity among strains were less pronounced than for
AX (Table 2). Porphyromonas gingivalis K- was the most affected
(14mm) and Staphylococcus aureus—the least (6mm). None of
the strains were inhibited by the AX blank (0mm).
For most strains the MICs and MBCs for AX were ≤638mg/l
SP. Except for L. acidophilus—2550mg/l SP, S. aureus and S. san-
guinis—1275mg/l SP (Table 3). TheMBCs andMICs for AXwere
nearly the same (Table 3).
PILOT CLINICAL STUDY
Of 26 participants initially enrolled in the study, one par-
ticipant dropped out for a reason unrelated to the study
(Table 4, Figure 2). The duration of overnight plaque accumu-
lation assessed at the pre-experimental and the baseline visits
ranged from 10 to 16 h with an average of 13 h (SD 2.9). At the
baseline appointment, the mean level of gingival health of the
participants, as assessed by Bleeding on Marginal Probing BOMP
in two contra-lateral quadrants, was 1.15 (SD 0.33) (Table 4).
The mean bleeding scores at the sampled teeth (total of 12 buc-
cal sites from four pre-selected teeth) was 0.98 (SD 0.43), which
corresponds to 51% bleeding (SD 23).
Plaque scores did not differ significantly between the pre-
experimental visit and baseline (p = 0.193), while plaque scores
increased significantly (p = 0.014) during a week without any
additional oral hygiene measures but with twice-daily use of AX
mouthwash (Table 5).
Compliance to the rinsing protocol was assessed by weighing
the bottles at the baseline and 7 days later at the post-experimental
visit. The difference was on average 140 g (±14 g), which implied
on average 14 servings of 10ml complying with the individual
instructions for use given.
In total 19 participants provided evaluable microbiological
data. The data of three participants were excluded due to the tech-
nical reasons in sample processing, and another three—due to
low reads (<850) per sample in one of the samples after the filter-
ing steps of the sequencing data. The remaining 54 samples had
on average 3135 reads/samples (SD 1047). The total of 169,309
reads were classified into 15 phyla, with Actinobacteria (39% of
the reads) and Firmicutes (31%) dominating the data, followed by
Proteobacteria (19%), Bacteroidetes (7.5%), Fusobacteria (3.1%)
and Candidate division TM7 (0.3%).
After subsampling at 850 reads/sample, the diversity and tax-
onomic comparisons among the three visits (pre-experimental,
baseline and post-experimental) were performed. Shannon diver-
sity index, taking into account the abundance of each OTU as
well as the number of OTUs, significantly increased from pre-
experimental to baseline visit from 2.67 (SD 0.29) to 2.79 (SD
0.29) (p = 0.02) and significantly decreased at post-experimental
visit to 2.09 (SD 0.39) (p < 0.001).
Genera Corynebacterium (21% of reads) and Streptococcus
(16–20%) dominated the pre-experimental and baseline samples.
Both of these genera were significantly affected by the treatment
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FIGURE 1 | Effects of Ardox-X®-technology (AX), Blank AX and
Chlorhexidine (CHX) on inhibition of oral bacterial strains in agar diffusion
assay. Inhibition zone size is expressed in mm (mean of triplicate experiment,
except duplicate for Aa and Fn). The strains (Table 1) used were: Pm,
Parvimonas micra; Porphyromonas gingivalis (Pg K1). (Pg K-). (Pg K6); An,
Actinomyces naeslundii; Fn, Fusobacterium nucleatum; Cr, Campylobacter
rectus; Sa, Staphylococcus aureus; Aa, Aggregatibacter
actinomycetemcomitans; La, Lactobacillus acidophilus; Vp, Veillonella parvula;
Ss, Streptococcus sanguinis; Sm, Streptococcus mutans; Pi, Prevotella
intermedia; Pn, Prevotella nigrescens; Tf, Tannerella forsythia.
Table 2 | Results of the Agar Diffusion assay, performed in triplicate.
Strain Concentration of Ardox-X® technology
0.2% CHX 0.12% CHX 5 SE 7 SE 10 SE* 15 SE 20 SE
Mean (SD) Diff. Mean (SD) Diff. Mean (SD) Diff. Mean (SD) Diff. Mean (SD) Diff. Mean (SD) Diff. Mean (SD) Diff.
An 11 (0) cd 9 (1) cdef 0 NA b 0 NA d 1 (1) cd 1 (1) cde 2 (1) def
Cr 10 (1) cdef 9 (1) def 1 (1) ba 1 (1) cd 2 (1) b 4 (1) b 6 (1) bc
La 10 (2) cdef 9 (0) def 0 NA b 0 NA d 0 NA d 0 NA e 0 NA fg
Pm 9 (1) def 8 (1) fgh 1 (2) ba 1 (1) bcd 1 (1) cd 2 (1) bcde 2 (1) def
Pg K- 14 (1) a 13 (1) a 1 (1) ba 2 (1) bcd 2 (1) bd 3 (1) bcde 4 (1) cd
Pg K1 14 (1) a 12 (1) ab 0.7 (0.6) ba 1 NA cd 2 (0) bd 2 (1) bcde 2.7 (0.6) de
Pg K6 13 (1) ab 12 (0) abc 1 (1) ba 2 (1) abc 2 (1) bd 3 (1) bcde 4 (1) cd
Pi 11 (1) bcd 10 (2) bcde 2.7 (0.6) a 4 (1) abc 5 (1) a 7 (1) a 9 (1) a
Pn 13 (1) bac 11 (1) abcd 3 (1) a 2.7 (0.6) abc 6 (1) a 7 (2) a 9 (2) a
Sa 6 (1) f 6 (0) h 0 NA b 0 NA d 0 NA d 0.3 (0.6) de 1 (1) efg
Sm 9 (1) cdef 9 (1) efg 0 NA b 0 NA d 0 NA d 0 NA e 0 NA g
Ss 7 (1) ef 6 (1) gh 0 NA b 0 NA d 0 NA d 0 NA e 0 NA fg
Tf 13 (1) ab 12 (0) abc 1 (1) ba 1 NA cd 2 (1) bc 3 (1) bcde 4 (1) cd
Vp 9 (1) def 8 (2) fgh 0 NA b 1 (1) d 2 (1) bc 2 (0) bcde 3 (0) de
Aa** 10 (1) 8 (1) 0 NA 0 NA 1 (1) 1 (1) 2 (1)
Fn** 12 (1) 11 (1) 1 (1) 1 (1) 2.5 (0.6) 3.5 (0.7) 5 (1)
Mean size of the inhibition zones (mm) and standard deviation. Diff., Different letters indicate statistically significant difference among the different bacterial strains
per-compound (within each column) (p < 0.05; ANOVA, Tukey B-test). *n = 6; **Excluded from analysis (n = 2); NA, not applicable; SE, standard equivalent units.
period: Corynebacterium was reduced to 2% and Streptococcus—
increased to 32% (Figure 3). Additionally, genus Veillonella
showed significant increase from 2–3 to 12% after the treatment,
while genus Derxia showed significant decrease from 3 to 0.7%,
respectively (Figure 3). Genus Leptotrichiawas nearly absent after
the experimental period, while it constituted approximately 2%
of the reads at the pre-experimental and baseline visits. Genus
Prevotella was present at a very low proportion—between 1 and
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Table 3 | MICs and MBCs of Ardox-X® technology for the 16 strains
studied, expressed as sodium perborate (SP) concentration in the
compound.
Bacteria strain MIC MBC
SP mg/l Range SP mg/l Range
An 319 319–638 319 319–638
Aa 159 80–319 319 80–638
Cr 159 NA 638 319–638
Fn 159 159–319 159 159–319
La 2550 1275–2550 2550 1275–2550
Pm 638 638–1275 638 638–1275
Pg K- 319 NA 319 319–638
Pg K1 319 NA 638 NA
Pg K6 159 80–159 159 NA
Pi 80 40–80 80 80–159
Pn 80 80–159 80 80–159
Sa 1275 638–1275 1275 638–1275
Sm 638 638–1275 638 638–1275
Ss 1275 638–1275 1275 638–1275
Tf 319 159–319 319 159–319
Vp 159 NA 159 NA
Values are median (range) of experiment in triplicate. NA, not applicable due to
equal values.
Table 4 | Subject demographics and their periodontal health.
N 25
Female/Male 17/8
Age in years, mean (SD) 21.5 (1.9)
DPSI*
1 1
2 11
3− 13
BOMP**, mean (SD) 1.15 (0.33)
*Dutch periodontal screening index (Mantilla Gomez et al., 2001).
**Bleeding on marginal probing (BOMP) at baseline (van der Weijden et al.,
1994a,b; Lie et al., 1998).
1.5% of the reads throughout the study and showed no significant
effect of the treatment.
To identify theOTUs that contribute to the differences between
the visits, an OTU-category significance test using paired sam-
ples T-test was performed, corrected for multiple comparisons
(75) using Bonferroni correction. No OTUs differed signifi-
cantly between the pre-experimental and baseline visits, while
10 OTUs differed between the baseline and post-experimental
visit (Table 6). Two OTUs—OTU169, classified as Veillonella, and
OTU113, classified as Streptococcus (blast: Streptococcus sangui-
nis SK1, 100% ID) increased. From the eight OTUs that showed
a significant decrease, OTU197 was identified as Streptococcus
cristatus (100% blast ID) and OTU183—as Leptotrichia hongkon-
gensis (100% blast ID), while the remaining six OTUs (Table 6)
could not be identified at species level.
Next, the microbiome profile data were ordinated by apply-
ing principal component analysis (PCA) (Figure 4). The first
principal component (PC1) explained 27% of the overall variance
among the samples and showed a clear separation of the pre-
experimental (black dots, Figure 4) and baseline samples (blue
dots, Figure 4) from the post-experimental samples (red dots in
Figure 4). The second component explained 11%of the total vari-
ance and separated the samples belonging to subjects Nr 1 and Nr
31 from the rest (Figure 4).
DISCUSSION
The in vitro experiments of this study indicated that oxygen-
releasing compound Ardox-X® technology (AX) selectively
inhibits oral bacteria, with anaerobe Gram-negative species being
the most sensitive. These promising findings were further tested
in vivo, during a pilot clinical study with experimental period
without any oral hygiene measures but twice-daily rinse with
mouthwash containing AX. After a week of non-brushing, the
plaque scores increased, while the microbial composition showed
a shift toward compositionally less diverse plaque, dominated by
primary colonizing genera Streptococcus andVeillonella compared
to the Corynebacterium dominated plaque at the baseline.
It has been proposed that in order to study the effects of a
mouthwash, a population with a high amount of plaque should
be studied (Wennstrom, 1988). The study population therefore
included individuals that proved to be good plaque formers at
the screening visit. Moreover, it is known that the periodon-
tal condition affects the rate of supragingival plaque forming
(Hillam and Hull, 1977; Rowshani et al., 2004). Participants
showed to have moderate gingivitis at baseline whereby 51%
of the sampled sites were bleeding on marginal probing. The
one-month interval between the pre-experiment assessment and
baseline did not result in significant changes in plaque scores or
in plaque composition of the study population. This is in line
with previous studies, which have demonstrated the stability of
the oral microbiome (Zhou et al., 2013). Microbial composition
of the supragingival plaque in this gingivitis population 1 month
before the experiment and at the baseline resembled mature
plaque (Haffajee et al., 2009) and plaque associated with gingivitis
(Huang et al., 2011). The major taxon in these samples was iden-
tified as Corynebacterium, a Gram-positive, facultatively anaerobe
bacterium that resembles Gram-negatives with respect to the lipid
layer in the cell membrane (John, 1984). Corynebacterium is asso-
ciated withmature plaque and is found in dental calculus (Moorer
et al., 1993).
The participants of the classical experimental gingivitis model
(Loe et al., 1965; Theilade et al., 1966) received a prophylaxis
and subsequently refrained from oral hygiene for 21 days induc-
ing an acute stage of inflammation in otherwise healthy subjects.
For the present study a seven-day model was chosen since the
purpose was not to change the level of gingival health but to
assess the effects on the microbial composition of undisturbed
plaque. In the absence of oral hygiene, bacterial re-colonization
increases after professional oral hygiene reaching or exceeding
pre-prophylaxis levels at 2 days (Uzel et al., 2011) and de novo
plaque formation reaches a stable microbial community between
4 and 7 days (Uzel et al., 2011). Higher diversity of mature
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FIGURE 2 | Flow chart and timeline of the pilot clinical study.
Table 5 | Mean (SD) and range of Plaque index scores.
Mean Min Max p-value*
Pre-experimental 2.27 (0.34) 1.68 3.01 0.193 Pre-experimental
vs. Baseline
Baseline 2.21 (0.31) 1.60 3.12 0.014 Baseline vs. Post-
experimental
Post-experimental 2.43 (0.39) 1.63 3.26
*Wilcoxon Signed Ranks test.
supragingival plaque compared to younger plaque has been found
in a recent experimental gingivitis study (Kistler et al., 2013). In
the present study after the baseline assessment, the participants
received a thorough professional oral hygiene and were not
allowed to brush their teeth for 1 week. Instead, they were asked to
perform a twice daily rinsing with AX-containing mouthwash. As
expected, the plaque amount increased during the experimental
period. The composition of the sampled plaque also changed
impressively, whereby microbial diversity had decreased signif-
icantly, when compared to the pre-experimental and baseline
visits. Genus Corynebacterium was considerably reduced, while
streptococci, Veillonella and Haemophilus—all health-associated
primary colonizers (Colombo et al., 2009; Simon-Soro et al.,
2013)—dominated the post-experimental plaque.
In vitro diffusion and susceptibility tests showed that AX is
highly selective in inhibiting oral bacteria. The Gram-negative
anaerobes such as prevotellas, but also Veillonella, Tannarella,
Campylobacter, Fusobacterium, and Porphyromonas were highly
sensitive, while streptococci and lactobacilli, facultative anaerobe
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FIGURE 3 | Average proportions of major genera from dental
plaque samples collected at pre-experimental, baseline and
the post-experimental visit. Error bars—standard deviations.
Horizontal lines indicate statistically significantly different
proportions of reads of the respective genera between the
post-experimental and the other two visits (p < 0.05, Wilcoxon
signed ranks test, after Bonferroni correction for multiple
comparisons). N = 19.
Table 6 | Significantly differently abundant OTUs between baseline
and post-experimental visit and their abundance in plaque samples.
OTU#* Number of reads (SD)
Pre- Baseline Post-
experimental experimental
113.Streptococcus 155 (52) 128 (53) 258 (93)
120.Corynebacterium 153 (93) 158 (84) 13 (15)
169.Veillonella 28 (43) 16 (14) 106 (61)
16.Corynebacterium 23 (21) 20 (15) 3 (6)
183.Leptotrichia 11 (8) 9 (7) 0.05 (0.2)
251.Capnocytophaga 7 (7) 9 (7) 2 (3)
197.Streptococcus 7 (8) 6 (4) 0.2 (0.5)
245.Cardiobacterium 6 (6) 8 (6) 2 (2)
Samples were randomly subsampled to 850 reads/sample. *OTUs that
remained significant after OTU-significance Paired samples T-test, Bonferroni
correction, p ≤ 0.001; N = 19.
Gram-positive bacteria, were not inhibited even by the highest
dose of AX tested in the diffusion test. In the clinical samples
genus Prevotella were found at very low levels throughout the
study and no effect of AX was discernible. However, other
Gram-negative taxa such as genera Derxia and Leptotrichia,
as well as OTUs classified as Cardiobacterium (OTU#245) and
Capnocytophaga (OTU#251) were significantly reduced dur-
ing the experimental period. Unfortunately, in vitro tests did
not include any genus Corynebacterium species which allows
FIGURE 4 | Principal Component Analysis (PCA) plot of microbiome
samples from pre-experimental visit (black dots); baseline of the
experimental period (green dots) and post-experimental visit (red
dots). The first component (PC1) explained 27% of the total variance, the
PC2—11%. The same labels indicate samples that originated from the
same individual.
only for speculation whether this Gram-positive bacterium with
the characteristics of Gram-negatives (John, 1984) was also
highly susceptible to exposure to AX. Alternatively its nearly
complete elimination from the post-experimental plaque sam-
ples could have other reasons for instance its growth could have
Frontiers in Cellular and Infection Microbiology www.frontiersin.org July 2014 | Volume 4 | Article 95 | 8
Fernandez y Mostajo et al. Effect of oxygenating agent on oral bacteria
been inhibited due to ecological shifts in the entire commu-
nity (Bradshaw et al., 1989). Another intriguing bacteria was
Veillonella—anaerobe Gram-negative bacteria, associated with
early supragingival plaque (Li et al., 2004; Haffajee et al., 2009).
Although Veillonella was found to be susceptible to AX in in vitro
testing, this genus showed a significant increase after the exper-
imental period with twice-daily exposure to the AX mouth-
wash. This could be attributed to the “pioneering” function
of this bacteria; it is found in healthy individuals, in young
supragingival plaque, in similar proportions with streptococci
(Keijser et al., 2008; Haffajee et al., 2009). Veillonellae are sec-
ondary fermenters—they consume lactic acid produced during
glucose fermentation by streptococci (Keller and Surette, 2006;
Periasamy and Kolenbrander, 2010) and produce other, weaker
acids such as acetic and propionic acid. By doing so, the envi-
ronmental conditions are created that promote growth of both
of these genera (Bradshaw et al., 1989). The most likely explana-
tion of the increase of genus Veillonella during the experimental
period, although sensitive to direct exposure to AX in vitro,
could be related to this ecologically beneficial relationship with
streptococci.
The selective inhibition of oral bacteria by AX is of interest
with respect to gingival and periodontal diseases, since infections
associated with Gram-negatives would be selectively suppressed
whereas the microorganisms regarded as more beneficial for peri-
odontal health such as streptococci and lactobacilli would not.
Several in vitro studies (Teughels et al., 2007; van Essche et al.,
2012) and recent clinical studies (Iniesta et al., 2012; Teughels
et al., 2013; Yanine et al., 2013) have suggested that these allegedly
beneficial bacteria can cause antagonism toward Gram-negative
bacteria.
In the agar diffusion assay, AX had significantly lower
inhibitory effect than CHX. The activity of AX could have
been limited to a short period right after its administration
until the active component is broken down and oxygen is
released. CHX is known to retain its activity for a longer time
period after a single application in vitro (Carrilho et al., 2010).
The only other study that has assessed the antimicrobial effect
of AX, showed that the AX containing product had higher
antimicrobial capacity than chlorhexidine toward monospecies
bacterial biofilm and microcosm obtained from pooled saliva
(Ntrouka et al., 2011).
So far, chlorhexidine (CHX) has proven to be the most effec-
tive antimicrobial agent in clinical dentistry and is considered as
the “gold standard” disinfectant in dental research (Jones, 1997;
Arweiler et al., 2001). Although it is widely used in periodontics
and is among the most effective compounds preventing plaque
formation (Addy, 1986), it has several side effects (Keijser et al.,
2003; Gurgan et al., 2006) and thereforemay result in poor rinsing
compliance by patients (Addy and Moran, 1985; Cortellini et al.,
2008; Van Strydonck et al., 2012). Optimizing anti-plaque agents,
reducing their side effects while at the same time taking care that
the oral microbiota are kept in balance with oral health has ini-
tiated interest in the development of other chemotherapeutical
agents. Interestingly, AX showed selective inhibition of oral bac-
teria that may contribute to this demanding balance and deserves
further investigation.
The lack of controls is a major limitation of this study that
could have potential bias on the interpretation of this study out-
comes. This pilot however indicates a potential rationale for more
elaborate studies with a randomized clinical trial protocol that
would include both a positive control such as CHX, and a nega-
tive control without any antimicrobial effects. The potential effect
of AX on reductions in both the clinical manifestations of gin-
givitis and the inhibition of or reduction of plaque or plaque
pathogenicity still needs to be demonstrated. For that purpose
a 21 days experimental gingivitis model could be used or alter-
natively a 4-week trial among gingivitis subject as proposed by
the American Dental Association in their Acceptance Guidelines
of Chemotherapeutic Products for Control of Gingivitis (ADA,
Acceptance Guidelines, 2008).
In conclusion, a mouthwash containing the oxygenating agent
Ardox-X® technology showed potential for selective inhibition
of oral bacteria. Twice-daily exposure for 1 week to this mouth-
wash resulted in a shift in the microbial composition toward a less
diverse and less mature plaque. The clinical consequences of this
shift in the oral microbiota need to be established.
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